# Nuvectis Pharma, Inc.: Form 8-K, filed May 15, 2023

- Company: [Nuvectis Pharma, Inc.](/companies/nvct.md) (CIK 1875558)
- Form: 8-K
- Filed: 2023-05-15
- Accepted by EDGAR: May 15, 2023, 08:22 ET
- Period: 2023-05-15
- Accession: 0001104659-23-060239
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1875558/000110465923060239/tm2315778d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1875558/000110465923060239/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1875558/000110465923060239/tm2315778d1_8k.htm

Filed May 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-060239. Last ingested by Listed: Nov 4, 2026, 08:08 ET. No prices; not investment advice.